Statistics for Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models

Total visits

views
Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models 4

Total visits per month

views
April 2025 0
May 2025 0
June 2025 2
July 2025 0
August 2025 0
September 2025 1
October 2025 1

File Visits

views
tcr-14-03-1531.pdf 3